Clinical trial MO29112
A multi-centre randomized clinical trial of Biomarker-Driven maintenance treatment for first-line metastatic colorectal cancer (MODUL)
| Cancers | |
|---|---|
| Organ | Colon |
| Trial status | Trial closed |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | Roche |
| EudraCT Identifier | 2014-001017-61 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02291289 |
| Inclusion criteria | first line RECIST 1.1 |
| Last update |